Phyto-liposomes as nanoshuttles for water-insoluble silybin-phospholipid complex

International Journal of Pharmaceutics

Volumn 471, Issue 1-2, 2014, Pages 173-181

  Angelico, Ruggero ^a,e   Ceglie, Andrea ^a,e   Sacco, Pasquale ^b   Colafemmina, Giuseppe ^c,e   Ripoli, Maria ^d   Mangia, Alessandra ^d  

^a UNIVERSITY OF MOLISE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^e CSGI Consorzio per lo Sviluppo dei Sistemi a Grande Interfase   (Italy)

Author keywords

Physicochemical properties; Phyto liposome; Phytosome; Silybin; Silybin phospholipids interactions

Indexed keywords

GLYCYRRHETINIC ACID PHOSPHOLIPID COMPLEX; HYDROGEN; LIPOSOME; PHOSPHOLIPID; SILIBININ; SILIPHOS; UNCLASSIFIED DRUG; DRUG CARRIER; NANOMATERIAL; SILYMARIN; WATER;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; FLUORESCENCE MICROSCOPY; HYDRODYNAMICS; HYDROGEN BOND; LASER DOPPLER FLOWMETRY; LIVER PROTECTION; NUCLEAR OVERHAUSER EFFECT; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROFLUOROMETRY; ZETA POTENTIAL; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; DRUG FORMULATION; HUMAN; SOLUBILITY; SURFACE PROPERTY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; LIPOSOMES; MOLECULAR STRUCTURE; NANOSTRUCTURES; PARTICLE SIZE; PHOSPHOLIPIDS; SILYMARIN; SOLUBILITY; SURFACE PROPERTIES; WATER;

EID: 84901823472     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.05.026     Document Type: Article

References (61)

1. R. Agarwal, C. Agarwal, H. Ichikawa, R.P. Singh, and B.B. Aggarwal Anticancer potential of silymarin: from bench to bed side Anticancer Res. 26 2006 4457 4498 (Pubitemid 46031522)
2. R. Angelico, G. Palazzo, U. Olsson, L. Ambrosone, and A. Ceglie Structural investigation on lecithin/cyclohexane solutions Prog. Colloid Polym. Sci. 112 1999 1 4
3. R. Angelico, A. Ceglie, F. Cuomo, C. Cardellicchio, G. Mascolo, and G. Colafemmina Catanionic systems from conversion of nucleotides into nucleo-lipids Langmuir 24 2008 2348 2355 (Pubitemid 351542629)
4. R. Angelico, I. Losito, F. Cuomo, A. Ceglie, and F. Palmisano Alkylation of complementary ribonucleotides in nanoreactors Phys. Chem. Chem. Phys. 15 2013 586 595
5. R. Angelico, M. Carboni, S. Lampis, J. Schmidt, Y. Talmon, M. Monduzzi, and S. Murgia Physicochemical and rheological properties of a novel monoolein-based vesicle gel Soft Matter 9 2013 921 928
6. T.-C. Bai, G.-B. Yan, J. Hu, H.-L. Zhang, and C.-G. Huang Solubility of silybin in aqueous poly(ethylene glycol) solution Int. J. Pharm. 308 2006 100 106 (Pubitemid 43097240)
7. T.-C. Bai, J.-J. Zhu, J. Hu, H.-L. Zhang, and C.-J. Huang Solubility of silybin in aqueous hydrochloric acid solution Fluid Phase Equilibr. 254 2007 204 210 (Pubitemid 46660375)
8. S.A. Begum, M. Sahai, and A.B. Ray Non-conventional lignans: coumarinolignans, flavonolignans, and stilbenolignans A.D. Kinghorn, Progress in the Chemistry of Organic Natural Products vol. 93 2010 Springer-Verlag Wien 1 70 10.1007/978-3-7091-0140-7-1
9. S. Bhattacharya, and A.K. Ghosh Phytosomes: the emerging technology for enhancement of bioavailability of botanicals and nutraceuticals Int. J. Aesthetic Anti-ageing Med. 2 2009 87 91
10. K.J. Blight, J.A. McKeating, and C.M. Rice Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication J. Virol. 76 2002 13001 13014 (Pubitemid 35386984)
11. M. Borsari, C. Gabbi, F. Ghelfi, R. Grandi, M. Saladini, S. Severi, and F. Borella Silybin, a new iron-chelating agent J. Inorg. Biochem. 85 2001 123 129 (Pubitemid 32611605)
12. T.D.W. Claridge High-Resolution NMR Techniques Organic Chemistry 2nd ed. 2008 Elsevier Amsterdam
13. A. Comoglio, A. Tomasi, S. Malandrino, G. Poli, and E. Albano Scavenging effect of silipide, a new silybin-phospholipid complex on ethanol-derived free radicals Biochem. Pharm. 50 1995 1313 1316
14. F.A. Crocenzi, and M.G. Roma Silymarin as a new hepatoprotective agent in experimental cholestasis: new possibilities from an ancient medication Curr. Med. Chem. 13 2006 1055
15. F. Cuomo, F. Lopez, A. Ceglie, L. Maiuro, M.G. Miguel, and B. Lindman pH-responsive liposome-templated polyelectrolyte nanocapsules Soft Matter 8 2012 4415 4420
16. M.S. El-Samaligy, N.N. Afifi, and E.A. Mahmoud Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance Int. J. Pharm. 319 2006 121 129 (Pubitemid 44051811)
17. M. Forster, M.A. Bolzinger, H. Fessi, and S. Briancon Topical delivery of cosmetics of drugs molecular aspects of percutaneous absorption and delivery Eur. J. Dermatol. 19 2009 309 323
18. H. Fu, Y. Katsumura, M. Lin, and Y. Muroya Laser photolysis and pulse radiolysis studies on silybin in ethanol solutions Radiat. Phys. Chem. 77 2008 1300 1305
19. R. Garg, and G.D. Gupta Gastroretentive floating microspheres of silymarin: preparation and in vitro evaluation Trop. J Pharm. Res. 9 2010 59 66
20. R. Gažák, A. Svobodova, J. Psotova, P. Sedmera, V. Prikrylova, D. Walterová, and V. Křen Oxidized derivatives of silybin and their antiradical and antioxidant activity Bioorg. Med. Chem. 12 2004 5677 5687 (Pubitemid 39304066)
21. R. Gažák, D. Walterová, and V. Křen Silybin and silymarin-new and emerging applications in medicine Curr. Med. Chem. 14 2007 315 338
22. J. Guedj, H. Dahari, R.T. Pohl, P. Ferenci, and A.S. Perelson Understanding silibinin's modes of action against HCV using viral kinetic modeling J. Hepatol. 56 2012 1019 1024
23. Colloid Science: Zeta Potential in Colloid Science: Principles and Applications R.J. Hunter 1981 Academic Press UK
24. J. Keeler Understanding NMR Spectroscopy 2nd ed. 2010 John Wiley & Sons New York Chapter 9
25. V. Křen, J. Kubisch, P. Sedmera, P. Halada, V. Prikrylova, A. Jegorov, L. Cvak, R. Gebhardt, J. Ulrichova, and V. Simanek Glycosylation of Silybin J. Chem. Soc. Perkin Trans. I 1997 2467
26. V. Křen, and D. Walterová Silybin and silymarin-new effects and applications Biomed. Pap. 149 2005 29
27. J. Kubisch, P. Sedmera, P. Halada, R. Gažák, N. Skottova, V. Simanek, and V. Křen Chemoenzymatic preparation of oligoglycosides of silybin, the flavonolignan from silybum marianum Heterocycles 53 2001 901
28. D. Kumar, D. Sharma, G. Singh, M. Singh, and M. Singh Rathore Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery ISRN Pharm. 2012 1 14 10.5402/2012/474830 Article ID 474830
29. V.A. Kurkin, and G.G. Zapesochnaya Flavolignans and other natural lignoids: problems of structural analysis Chem. Nat. Compd. 23 1987 7
30. V.A. Kurkin, V.M. Ryzhov, O.V. Biryukova, N.B. Mel'nikova, and V.V. Selekhov Interaction of milk-thistle-fruit flavanonols with Langmuir monolayers of lecithin and bilayers of liposomes Pharm. Chem. J. 43 2009 101 109
31. M.L. Immordino, F. Dosio, and L. Cattel Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int. J. Nanomed. 1 2006 297 315
32. D.Y.-W. Lee, and Y. Liu Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, isolated from Silybum marianum (milk thistle) J. Nat. Prod. 66 2003 1171 1174 (Pubitemid 37204213)
33. J.I. Lee, M. Narayan, and J.S. Barrett Analysis and comparison of active constituents in commercial standardized silymarin extracts by liquid chromatography-electrospray ionization mass spectrometry J. Chromatogr. B 845 2007 95 103 (Pubitemid 44839299)
34. L. Liu, X. Pang, W. Zhang, and S. Wang Formulation design and in vitro evaluation of silymarin-loaded self-microemulsifying drug delivery systems Asian J. Pharm. Sci. 2 2007 150 160
35. G. Mangiapia, G. Vitiello, C. Irace, R. Santamaria, A. Colonna, R. Angelico, A. Radulescu, G. D'Errico, D. Montesarchio, and L. Paduano Anticancer cationic ruthenium nanovectors: from rational molecular design to cellular uptake and bioactivity Biomacromolecules 14 2013 2549 2560
36. K.R. Markham, and T.J. Mabry Ultraviolet-visible and proton magnetic resonance spectroscopy of flavonoids J.B. Harborne, T.J. Mabry, H. Mabry, The Flavonoids, Part 1 1975 Academic Press New York 45
37. K. Maruyama Passive targeting with liposomial drug carriers Drug Deliv. Syst. 14 1999 433 447
38. M. Meloun, D. Burkonová, T. Syrový, and A. Vrána Thermodynamic dissociation constants of silychristin, silybin, silydianin and mycophenolate by the regression analysis of spectrophotometric data Anal. Chim. Acta 486 2003 125 141 (Pubitemid 36694333)
39. ® SIL: the antidote of choice in patients with acute hepatotoxicity from amatoxin poisoning Curr. Pharm. Biotech. 13 2012 1964 1970
40. K. Moribe, K. Maruyama, and M. Iwatsuru Spectroscopic investigation of the molecular state of nystatin encapsulated in liposomes Int. J. Pharm. 201 2000 37 49 (Pubitemid 30364968)
41. 9- tetrahydrocannabinol solubilisation J. Colloid Interace Sci. 390 2013 129 136
42. J.G. Napolitano, D.C. Lankin, T.N. Graf, J.B. Friesen, S.-N. Chen, Mc Alpine, J.B. Oberlies, N.H. Pauli, and G.F HiFSA fingerprinting applied to isomers with near-identical NMR spectra: the silybin/isosilybin case J. Org. Chem. 78 2013 2827 2839
43. D. Neuhaus, and M.P. Williamson The Nuclear Overhauser Effect in Structural and Conformational Analysis 2nd ed. 2000 Wiley-VCH
44. S.D. Patil, and D.J. Burgess Liposomes: design and manufacturing D.J. Burgess, Injectable Dispersed Systems, Formulation, Processing, and Performance 2005 Taylor & Francis Group, LLC 249 303
45. M. Pliskova, J. Vondracek, V. Křen, R. Gažák, P. Sedmera, D. Walterová, J. Psotova, V. Simanek, and M. Machala Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation Toxicology 215 2005 80
46. N.P. Praetorius, and T.K. Mandal Engineered nanoparticles in cancer therapy Recent Patents Drug Deliv. Formulation 1 2007 37 51
47. L. Radko, and W. Cybulski Application of silymarin in human and animal medicine J. Pre-Clin. Clin. Res. 1 2007 022 026
48. M. Ripoli, R. Angelico, V. Piazzolla, R. Santoro, L. Mottola, D. Petruzzellis, and A. Mangia Effects of a new liposome-encapsulated formulation of silybin on hepatitis C virus infection J. Hepatol. 58 2013 S476
49. Ripoli, M., Angelico, R., Sacco, P., Mangia, A., 2014. Manuscript in preparation.
50. ® strategy to improve the bioavailability of phytochemicals Fitoterapia 81 2010 306 314
51. F. Szoka Jr, and D. Papahadjopoulos Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation Proc. Natl. Acad. Sci. U. S. A. 75 1978 4194 4198 (Pubitemid 9025976)
52. A. Tawheed, and S.V. Bhat A review on phytosome technology as a novel approach to improve the bioavailability of nutraceuticals Int. J. Adv. Res. Technol. 2012 43 57
53. S. Tripathy, D.K. Patel, L. Baro, and S.K. Nair A review on phytosomes, their characterization, advancement & potential for transdermal application J. Drug Deliv. Ther. 3 2013 147 152
54. H.J.V. Tyrrell, and K.R. Harris Diffusion in Liquids 1984 Butterworths London
55. A.S. Ulrich Biophysical aspects of using liposomes as delivery vehicles Biosci. Rep. 22 2002 129 150 (Pubitemid 35222729)
56. P. Van Hoogevest, M. Leigh, and A. Fahr Liposomes as intravenous solubilizers for poorly water-soluble drugs D. Douroumis, A. Fahr, Drug Delivery Strategies for Poorly Water-Soluble Drugs 2013 John Wiley & Sons UK 37 66
57. Y. Wei, X. Ye, X. Shang, X. Peng, Q. Bao, M. Liu, M. Guo, and F. Li Enhanced oral bioavailability of silybin by a supersaturatable self-emulsifying drug delivery system (S-SEDDS) Colloids Surf. A: Physicochem. Eng. Aspects 396 2012 22 28
58. K. Wellington, and B. Jarvis Silymarin: a review of its clinical properties in the management of hepatic disorder BioDrugs 15 2001 465 489 (Pubitemid 32783707)
59. O. Wesołowska, B. Łania-Pietrzak, M. Kużdż ał, K. Stańczak, D. Mosia̧dz, P. Dobryszycki, A. Ożyhar, M. Komorowska, A.B. Hendrich, and K. Michalak Influence of silybin on biophysical properties of phospholipid bilayers Acta Pharmacol. Sin. 28 2007 296 306 (Pubitemid 46155549)
60. J.S. Woo, T.-S. Kim, J.-H. Park, and S.-C. Chi Formulation and biopharmaceutical evaluation of silymarin using SMEDDS Arch. Pharm. Res. 30 2007 82 89
61. X. Yanyu, S. Yunmei, C. Zhipeng, and P. Qineng The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats Int. J. Pharm. 307 2006 77 82 (Pubitemid 41773254)